VMD
VMD (VMD) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 13,550 VND, little changed on the session, giving a market capitalization of 223.9 billion VND.
On valuation, VMD trades at a price-to-earnings ratio of 8.2 and a price-to-book of 0.5. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 6.5% points to modest profitability relative to the company's equity base, below the sector average of 11.5%. Trailing earnings per share stand at 1,778 VND.
Aveluro tracks 8 news items mentioning VMD, where recent coverage skews negative (100% of articles). The most recent catalyst was a regulation change event — "VMD Stock Moved to Restricted Trading on HOSE From September 16, 2026". Aveluro's composite model rates VMD 5.7/10 (Neutral), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Health Care sector include AGP, AMP and AMV.
VMD Stock Moved to Restricted Trading on HOSE From September 16, 2026
Recent developments around VMD include 5 notable classified events. On Sep 11, 2026, a market event was reported: VMD of Y Dược phẩm Vimedimex will move from controlled to restricted trading on HOSE from September 16, 2026 under Decision 702/QĐ-SGDHCM, after continued breaches of information disclosure rules. On Aug 07, 2026, a market event was reported: HOSE has expanded its margin-ineligible list to 57 securities, including Vietnam Airlines (HVN), Duc Giang Chemicals (DGC), and newly listed DMX. On Jun 12, 2026, a leadership change was reported: Vimedimex Pharmaceutical (VMD) faces a leadership shake-up as a board member and three supervisory board members resign ahead of the 2026 Annual General Meeting scheduled for June 12. On May 26, 2026, a market event was reported: ITD was added to HOSE's margin-cut list after receiving a tax penalty for fiscal years 2022-2025, totaling VND 630.6 million. On Apr 20, 2026, a market event was reported: HoSE placed VNE, DTA, VMD, and SBV under warning status from April 24, primarily for delayed submission of audited 2025 financial reports or reports receiving qualified audit opinions.
The overall tone of recent coverage is negative, with 5 of 5 events carrying bearish sentiment.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this